Evaluating Vancomycin Monotherapy and Dual Therapy with Nifuroxazide for Medium–Severe Clostridioides Difficile Infection
Background: All currently used therapeutic protocols and drugs for <i>Clostridioides difficile</i> infection (CDI) treatment do not have a satisfying success and usually cost a lot. Objectives: To compare the efficacy of vancomycin monotherapy vs modified dual therapy with vancomycin + n...
Saved in:
| Main Authors: | Jasna Rahimić, Ervin Alibegović, Lana Lekić, Marijana Marković Boras, Amina Džidić-Krivić, Esma Karahmet Farhat, Emina Karahmet Sher |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-04-01
|
| Series: | Antibiotics |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2079-6382/14/4/400 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Can Gut Microbiota Analysis Reveal <i>Clostridioides difficile</i> Infection? Evidence from an Italian Cohort at Disease Onset
by: Roberto Rosato, et al.
Published: (2024-12-01) -
Effectiveness and safety of «Nifuroxazide-ECO» in therapy of escherichioses in children
by: N. V. Gonchar, et al.
Published: (2021-03-01) -
Against <i>Clostridioides difficile</i> Infection: An Update on Vaccine Development
by: Jingyao Wang, et al.
Published: (2025-05-01) -
Potential for Misinterpretation in the Laboratory Diagnosis of <i>Clostridioides difficile</i> Infections
by: Alexandra Kalacheva, et al.
Published: (2025-05-01) -
Metronidazole and Vancomycin Have a Synergic Effect, with Plant Extracts as Helpful Tools to Combat <i>Clostridioides difficile</i> Infections
by: Nancy C. Ruiz-Pérez, et al.
Published: (2025-01-01)